RIL
ANAB icon

Rothschild Investment LLC’s AnaptysBio ANAB Stock Holding History

Rothschild Investment LLC’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Hold
165
– – ﹤0.01% 1822
2026
Q1 		$9.15K Hold
165
– – ﹤0.01% 1731
2025
Q4 		$8K Hold
165
– – ﹤0.01% 1665
2025
Q3 		$5.05K Sell
165
-20
-11% -$459 ﹤0.01% 1706
2025
Q2 		$4.11K Sell
185
-10
-5% -$209 ﹤0.01% 1602
2025
Q1 		$3.63K Buy
195
+185
+1,850% +$3.09K ﹤0.01% 1590
2024
Q4 		$132 Sell
10
-15
-60% -$363 ﹤0.01% 2871
2024
Q3 		$838 Buy
25
+20
+400% +$683 ﹤0.01% 2284
2024
Q2 		$125 Buy
+5
New +$116 ﹤0.01% 2655

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Rothschild Investment LLC's ANAB Position: Q2 2026 in Review

Rothschild Investment LLC held its AnaptysBio (ANAB) position steady in Q2 2026 at 165 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1822.

Rothschild Investment LLC first reported a position in ANAB in Q2 2024 and has held it in 9 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Rothschild Investment LLC held 165 shares of AnaptysBio worth $11.1K as of Q2 2026.
  • Rothschild Investment LLC left its AnaptysBio share count unchanged in Q2 2026.
  • AnaptysBio made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1822 holding.
  • Rothschild Investment LLC first reported a position in AnaptysBio in Q2 2024 and has held it in 9 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.